Regulatory Wrap-up of the year 2024 This overview highlights the key...
a&r News

Last Call for Substance-Based Medical Devices under MDD
Certain substance-based medical devices that are not yet certified under the...
EFSA released new guidance on novel foods
Time to comment! Let´s do it.EFSA just released new guidance documents for...
Meet a&r expert Dr. Heike Stier in Brussels
The demarcation between herbal medicinal products and supplements containing...
Biofortis and a&r join forces
Berlin, Germany and Nantes France, September 26, 2023 – Biofortis, a...
Impressions of Probiota 2023: Call for harmonisation and need for clinical trials
a&r’s managing director Dr. Volker Schehlmann was delighted to meet...
Clinical studies published in high impact journal
The results of two clinical trials have just been published in The American...
Why selecting the right manufacturing and development partner is crucial
At a panel discussion for Vitafoods Insights, analyze & realize Managing...
Follow-up Vitafoods
The a&r team was delighted to meet the leaders of the consumer healthcare...